⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 21, 2024The American Surgeon

Usefulness of the C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) Index as a Prognostic Indicator for Patients With Gastric Cancer

Keigo Nakashima Koichiro Haruki Teppei Kamada Junji Takahashi Masashi Tsunematsu Hironori Ohdaira Kenei Furukawa Yutaka Suzuki Toru Ikegami

View Full Paper

Ask AI

Bookmark

Share

Abstract

The C-reactive protein (CRP)-albumin-lymphocyte (CALLY) index is a novel immune nutrition scoring system associated with cancer prognosis. This study investigated the association between the CALLY index and the long-term outcomes of patients with gastric cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nakashima et al. (2024) studied this question.

synapsesocial.com/papers/68e6e3dbb6db64358765f362 https://doi.org/10.1177/00031348241248693

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Prognostic usefulness of the C-reactive protein-albumin-lymphocyte (CALLY) index as a novel biomarker in patients undergoing colorectal cancer surgery2024 · 66 citations
2The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment2024 · 22 citations
3C-Reactive Protein-Albumin-Lymphocyte Index (Cally) As A Prognostic Biomarker in Colorectal Cancer: A Systematic Review2025
4Prognostic Value of CRP–Albumin–Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer2024 · 50 citations
5The Potential of the C‐Reactive Protein‐Albumin‐ Lymphocyte (CALLY) Index as a Prognostic Biomarker in Colorectal CancerRetrospective Study · 2025 · 14 citations